July 2009 Newsletter

Hepatitis B and C Prevention

More than 4 million people in the United States are infected with hepatitis C and about 1.5 million people nationwide are infected with chronic hepatitis B. Hepatitis B and C are silent diseases, meaning they are difficult to detect because patients are often asymptomatic. Although hepatitis is curable, untreated hepatitis is a significant risk factor for liver cancer.

Screening and maintaining healthy lifestyle practices are key for prevention of hepatitis B and C. Rajender Reddy, MD, director of hepatology and medical director of the liver transplantation program at the Hospital of the University of Pennsylvania says: "Penn Medicine is at the cutting edge of research and development of new forms of therapy for treatment of hepatitis B and C."

Penn Gastroenterology is currently involved in 15 research studies and recently added four new hepatologists to the staff.

Read More . . .

Additional Articles:

• Pennsylvania Hospital's Pavilion Now Open
• A Program for Older Adults with Cancer

Announcements:

• Weight Loss Surgery Information Sessions
• Expansion of Emergency Department at Pennsylvania Hospital
  
• Physician Announcements
• South Street Bridge is Closed
• Shop at Penn Med is Now Opened!

View Current Issue

	Need an appointment? Request one online 24 hours/day, 7 days/week or call 800-789-PENN (7366) to speak to a referral counselor.

Related Links